Spectral AI subsidiary awarded up to $149M BARDA contract for DeepView burn imaging device

Spectral AI, Inc.

Total BARDA contract value up to $149M; initial award of $55M for DeepView clinical validation and FDA clearance.
Contract includes options up to $95M for additional development, procurement, and deployment.
Combined with prior awards, total BARDA support reaches nearly $251M; largest contract for SMD.
Up to 30 DeepView devices placed at burn centers for study; device has 92% diagnostic accuracy.
Contract supports U.S. government burn mass casualty preparedness; BARDA can terminate for convenience.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.